Am. J. Respir. Crit. Care Med., Volume 159, Number 4, April 1999, 1284-1288

Exhaled Nitric Oxide Concentrations during Treatment of Wheezing Exacerbation in Infants and Young Children

EUGENIO BARALDI, CINZIA DARIO, RICCARDO ONGARO, MASSIMO SCOLLO, NICOLETTA M. AZZOLIN, NICOLA PANZA, NICOLA PAGANINI, and FRANCO ZACCHELLO

Departments of Pediatrics and Anesthesia and Intensive Care, University of Padova, School of Medicine, Padova, Italy

While it is known that exhaled nitric oxide (ENO) is increased in adults and school children with asthma exacerbation probably as an expression of disease activity, no studies have investigated whether this phenomenon also occurs in infants and young children with recurrent wheeze exacerbation. We measured ENO in 13 young children (mean age 20.2 mo) with recurrent wheeze (Group 1) during an acute episode and after 5 d of oral prednisone therapy. ENO was measured also in nine healthy control subjects (Group 2) (mean age 16.9 mo) and in six children with a first-time viral wheezy episode (Group 3) (mean age 11 mo). To measure ENO, infants inhaled NO-free air via a face mask from a reservoir and, through a nonrebreathing valve, exhaled in a collecting bag that was analyzed by chemiluminescence. To address the question of whether the levels of ENO collected in the bag are a reflection of the pulmonary airway, ENO determinations were performed in two healthy infants before and after tracheal intubation for elective surgery. During the acute episode of wheezing the mean (± SEM) value of ENO in children with recurrent wheeze (Group 1) was 14.1 ± 1.8 ppb, almost threefold higher than in healthy control subjects (5.6 ± 0.5 ppb, p < 0.001). After steroid therapy we found a mean fall of 52% in ENO (5.9 ± 0.7 ppb, p < 0.01) compared with baseline values. ENO values measured before and after intubation in two infants were 6 ppb and 5 ppb in one child and 7 ppb and 6 ppb in the other one. The mean value of ENO of children with first-time wheeze (Group 3) was 8.3 ± 1.3 ppb, significantly lower (p < 0.05) than the value of children with recurrent wheeze (Group 1). In conclusion, we describe a method to measure ENO in young children and show that infants with recurrent wheeze have elevated levels of ENO during exacerbation that rapidly decrease after steroid therapy. This suggests that, in these children, airway inflammation could be present at a very early stage.

This article has been cited by other articles:

				P. L. P. Brand, E. Baraldi, H. Bisgaard, A. L. Boner, J. A. Castro-Rodriguez, A. Custovic, J. de Blic, J. C. de Jongste, E. Eber, M. L. Everard, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach Eur. Respir. J., October 1, 2008; 32(4): 1096 - 1110. [Abstract] [Full Text] [PDF]

				J. C. de Jongste To Wheeze or Not to Wheeze: Prospective FENO-typing in Early Infancy Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1281 - 1282. [Full Text] [PDF]

				D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF]

				R Ratnawati and P S Thomas Exhaled nitric oxide in paediatric asthma Chronic Respiratory Disease, July 1, 2005; 2(3): 163 - 174. [Abstract] [PDF]

				ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005 Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 912 - 930. [Full Text] [PDF]

				J. E. Brussee, H. A. Smit, M. Kerkhof, L. P. Koopman, A. H. Wijga, D. S. Postma, J. Gerritsen, D. E. Grobbee, B. Brunekreef, and J. C. de Jongste Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy Eur. Respir. J., March 1, 2005; 25(3): 455 - 461. [Abstract] [Full Text] [PDF]

				D. A. Straub, A. Moeller, S. Minocchieri, J. Hamacher, F. H. Sennhauser, G. L. Hall, and J. H. Wildhaber The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Eur. Respir. J., February 1, 2005; 25(2): 289 - 294. [Abstract] [Full Text] [PDF]

				D. A. Straub, S. Minocchieri, A. Moeller, J. Hamacher, and J. H. Wildhaber The Effect of Montelukast on Exhaled Nitric Oxide and Lung Function in Asthmatic Children 2 to 5 Years Old Chest, February 1, 2005; 127(2): 509 - 514. [Abstract] [Full Text] [PDF]

				U. Frey, C. Kuehni, H. Roiha, M. Cernelc, B. Reinmann, J. H. Wildhaber, and G. L. Hall Maternal Atopic Disease Modifies Effects of Prenatal Risk Factors on Exhaled Nitric Oxide in Infants Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 260 - 265. [Abstract] [Full Text] [PDF]

				F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF]

				P.J. Franklin, S.W. Turner, R.C. Mutch, and S.M. Stick Comparison of single-breath and tidal breathing exhaled nitric oxide levels in infants Eur. Respir. J., March 1, 2004; 23(3): 369 - 372. [Abstract] [Full Text] [PDF]

				T. Martinez, A. Weist, T. Williams, C. Clem, P. Silkoff, and R. S. Tepper Assessment of exhaled nitric oxide kinetics in healthy infants J Appl Physiol, June 1, 2003; 94(6): 2384 - 2390. [Abstract] [Full Text] [PDF]

				L P Malmberg, A S Pelkonen, T Haahtela, and M Turpeinen Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma Thorax, June 1, 2003; 58(6): 494 - 499. [Abstract] [Full Text] [PDF]

				M.W.H. Pijnenburg, E.T. Lissenberg, W. Hofhuis, L. Ghiro, W.C.J. Hop, W.P. Holland, and J.C. de Jongste Exhaled nitric oxide measurements with dynamic flow restriction in children aged 4-8 yrs Eur. Respir. J., October 1, 2002; 20(4): 919 - 924. [Abstract] [Full Text] [PDF]

				S. Godfrey Ups and Downs of Nitric Oxide in Chesty Children Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 438 - 439. [Full Text] [PDF]

				Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al. Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Eur. Respir. J., July 1, 2002; 20(1): 223 - 237. [Abstract] [Full Text] [PDF]

				W. Formanek, D. Inci, R.P. Lauener, J.H. Wildhaber, U. Frey, and G.L. Hall Elevated nitrite in breath condensates of children with respiratory disease Eur. Respir. J., March 1, 2002; 19(3): 487 - 491. [Abstract] [Full Text] [PDF]

				G. L. Hall, B. Reinmann, J. H. Wildhaber, and U. Frey Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure J Appl Physiol, January 1, 2002; 92(1): 59 - 66. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				E BARALDI and S ZANCONATO The labyrinth of asthma phenotypes and exhaled NO Thorax, May 1, 2001; 56(5): 333 - 335. [Full Text]

				Q Jöbsis, H C Raatgeep, W C J Hop, and J C de Jongste Controlled low flow off line sampling of exhaled nitric oxide in children Thorax, April 1, 2001; 56(4): 285 - 289. [Abstract] [Full Text]

				F. BUCHVALD and H. BISGAARD FeNO Measured at Fixed Exhalation Flow Rate during Controlled Tidal Breathing in Children from the Age of 2 Yr Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 699 - 704. [Abstract] [Full Text] [PDF]

				Y. J. KAO, P. A. PIEDRA, G. L. LARSEN, and G. N. COLASURDO Induction and Regulation of Nitric Oxide Synthase in Airway Epithelial Cells by Respiratory Syncytial Virus Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 532 - 539. [Abstract] [Full Text]

				E. BARALDI, M. SCOLLO, C. ZARAMELLA, S. ZANCONATO, and F. ZACCHELLO A Simple Flow-Driven Method for Online Measurement of Exhaled NO Starting at the Age of 4 to 5 Years Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1828 - 1832. [Abstract] [Full Text]